Peter Gray, Director at Jazz Pharmaceuticals plc (JAZZ), sold 704 shares at $173.85 ($122K) on 2015-05-12, disclosed to the SEC on 2015-05-14.
Open-market sale of $122k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $173.85 | 697 | $121K | 99.0% |
| 2 | $175.15 | 7 | $1K | 1.0% |
| Total | $173.86 avg | 704 | $122K | 100% |
| Filing → |
| JAZZ | SELL | 2022-08-09 | $359K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $418K | — | Filing → |
| JAZZ | SELL | 2019-08-12 | $214K | — | Filing → |